diagnosis
Real-World Outcomes of Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
Abstract
2025 Rockville Patient and Family Conference Session: PNH
In this recording, Dr. Bhumika Patel discusses what is new in PNH and current treatment options available to patients.
2025 Patient and Family Conference Session: MDS and MPNs
In this recording, Dr. Catherine Lai discusses MDS and how patients can also be diagnosed with MPN's. Her presentation discusses the treatment options available to patients and resources.
2025 Rockville Patient and Family Conference: Debra's Story - Aplastic Anemia
2025 Rockville Patient and Family Conference: Low Risk MDS
In this recording, Dr. Ball Brian discusses low risk MDS and current treatment options.
2025 Rockville Patient and Family Conference Session: Aplastic Anemia
MDS/MPN Overlap
In this webinar, Dr. David Sallman discusses the diagnosis of MDS and MPN, treatment options available to patients and symptom management.
Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT
For patients with myelodysplastic neoplasm/syndrome (MDS), allogeneic hematopoietic cell transplantation (allo-HCT) represents the only potentially curative treatment, capable of eradicating disease-related mutant hematopoietic cells and establishing normal donor hematopoiesis.